Futura Medical (LON:FUM) Stock Price Up 18.1% – Should You Buy?

Futura Medical plc (LON:FUM) shares shot up 18.1% during trading on Monday . The stock traded as high as GBX 0.70 and last traded at GBX 0.64. Approximately 1,973,431 shares were traded during mid-day trading, a decline of 67% from the average session volume of 5,988,100 shares. The stock had previously closed at GBX 0.54.

Futura Medical Price Performance

The stock has a market capitalization of £3.72 million, a PE ratio of -0.23 and a beta of 0.02. The stock has a 50 day moving average of GBX 0.84 and a two-hundred day moving average of GBX 1.08.

Futura Medical (LON:FUM) last announced its quarterly earnings data on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. The business had revenue of GBX 170 million for the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. As a group, research analysts predict that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.